l-lysine
UkraineDrugs containing this active substance
-
The drug is used for the parenteral (intravenous) administration of amino acids in severe forms of hepatic insufficiency, with or without hepatic encephalopathy, if the patient cannot or is unable to receive nutrition via the mouth or intestines.
Form: solution for infusion
Active substance Dosage l-isoleucine 10.4 g/L l-leucine 13.09 g/L l-lysine 6.88 g/l l-methionine 1.1 g/L n-acetyl-l-cysteine 0.7 g/l l-phenylalanine 0.88 g/L l-threonine 4.4 g/L l-tryptophan 0.7 g/l l-valine 10.08 g/L l-arginine 10.72 g/L l-histidine 2.8 g/L glycine 5.82 g/L l-alanine 4.64 g/L l-proline 5.73 g/L l-serine 2.24 g/l acetic acid 4.42 g/L ATC: B05BA01
Manufacturer: Fresenius Kabi Austria GmbH
-
The drug is used as a component of parenteral (intravenous) nutrition for patients who cannot or cannot effectively be fed via the intestine. It contains amino acids necessary for metabolic processes and protein synthesis.
Form: solution for infusion
Active substance Dosage l-alanine 14.00 g/L l-arginine 12.00 g/L l-valine 6.20 g/L l-histidine 3.00 g/L glycine 11.00 g/L l-leucine 7.40 g/l l-lysine 6.60 g/l l-isoleucine 5.00 g/L l-methionine 4.30 g/l l-serine 6.50 g/L taurine 1.00 g/L l-proline 11.20 g/L l-tyrosine 0.40 g/L l-threonine 4.40 g/l l-tryptophan 2.00 g/l l-phenylalanine 5.10 g/l ATC: B05BA01
Manufacturer: Fresenius Kabi Austria GmbH
-
The drug is used as a component of parenteral (intravenous) nutrition for patients who cannot or cannot effectively be fed via the digestive tract. It is used in combination with energy sources such as glucose or lipid emulsions.
Form: solution for infusion
Active substance Dosage l-alanine 25.00 g/L l-arginine 20.00 g/L l-valine 5.50 g/l l-histidine 7.30 g/L glycine 18.50 g/L l-leucine 8.90 g/l l-lysine 11.10 g/L l-isoleucine 5.20 g/L l-methionine 3.80 g/l l-serine 9.60 g/L taurine 2.00 g/l l-proline 17.00 g/L l-tyrosine 0.40 g/L l-threonine 8.60 g/l l-tryptophan 1.60 g/l l-phenylalanine 5.50 g/l ATC: B05BA01
Manufacturer: Fresenius Kabi Austria GmbH
-
The drug is used for the treatment of patients with chronic renal failure, particularly those experiencing malnutrition syndrome undergoing peritoneal dialysis.
Form: solution for peritoneal dialysis
Active substance Dosage l-tyrosine 0.3 g l-tryptophan 0.27 g l-phenylalanine 0.57 g l-threonine 0.646 g l-serine 0.51 g l-proline 0.595 g glycine 0.51 g l-alanine 0.951 g l-valine 1393 g l-methionine 0.85 g l-isoleucine 0.85 g l-leucine 1.02 g l-lysine 0.955 g l-histidine 0.714 g l-arginine 1.071 g calcium chloride 0.184 g magnesium chloride 0.051 g sodium lactate 4.48 g sodium chloride 5.38 g ATC: B05DA
Manufacturer: Ventiv Manufacturing Limited